BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16723702)

  • 1. Transient neonatal estrogen exposure to estrogen-deficient mice (aromatase knockout) reduces prostate weight and induces inflammation in late life.
    Bianco JJ; McPherson SJ; Wang H; Prins GS; Risbridger GP
    Am J Pathol; 2006 Jun; 168(6):1869-78. PubMed ID: 16723702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-androgenic action by red clover-derived dietary isoflavones reduces non-malignant prostate enlargement in aromatase knockout (ArKo) mice.
    Jarred RA; McPherson SJ; Jones ME; Simpson ER; Risbridger GP
    Prostate; 2003 Jun; 56(1):54-64. PubMed ID: 12746847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland.
    McPherson SJ; Wang H; Jones ME; Pedersen J; Iismaa TP; Wreford N; Simpson ER; Risbridger GP
    Endocrinology; 2001 Jun; 142(6):2458-67. PubMed ID: 11356695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice.
    Prins GS; Birch L; Couse JF; Choi I; Katzenellenbogen B; Korach KS
    Cancer Res; 2001 Aug; 61(16):6089-97. PubMed ID: 11507058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia.
    McPherson SJ; Ellem SJ; Simpson ER; Patchev V; Fritzemeier KH; Risbridger GP
    Endocrinology; 2007 Feb; 148(2):566-74. PubMed ID: 17068134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delay of postnatal maturation sensitizes the mouse prostate to testosterone-induced pronounced hyperplasia: protective role of estrogen receptor-beta.
    Savolainen S; Pakarainen T; Huhtaniemi I; Poutanen M; Mäkelä S
    Am J Pathol; 2007 Sep; 171(3):1013-22. PubMed ID: 17640960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Estrogens on Adipokines and Glucose Homeostasis in Female Aromatase Knockout Mice.
    Van Sinderen ML; Steinberg GR; Jørgensen SB; Honeyman J; Chow JD; Herridge KA; Winship AL; Dimitriadis E; Jones ME; Simpson ER; Boon WC
    PLoS One; 2015; 10(8):e0136143. PubMed ID: 26317527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual dimorphism in the glucose homeostasis phenotype of the Aromatase Knockout (ArKO) mice.
    Van Sinderen M; Steinberg G; Jorgensen SB; Honeyman J; Chow JDY; Simpson ER; Jones MEE; Boon WC
    J Steroid Biochem Mol Biol; 2017 Jun; 170():39-48. PubMed ID: 27353462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of estrogenic responses with relevance to the metabolic syndrome and to menopausal symptoms in wild-type and aromatase-knockout mice.
    Bader MI; Wober J; Kretzschmar G; Zierau O; Vollmer G
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):428-34. PubMed ID: 21621614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age dependency of estrogen responsiveness in the uterus and adipose tissue of aromatase-knockout (ArKO) mice.
    Bader MI; Reitmayer C; Arndt C; Wober J; Kretzschmar G; Zierau O; Vollmer G
    J Steroid Biochem Mol Biol; 2012 Jan; 128(1-2):29-37. PubMed ID: 22019577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous estrogen deficiency reduces proliferation and enhances apoptosis-related death in vascular smooth muscle cells: insights from the aromatase-knockout mouse.
    Ling S; Dai A; Dilley RJ; Jones M; Simpson E; Komesaroff PA; Sudhir K
    Circulation; 2004 Feb; 109(4):537-43. PubMed ID: 14732746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of melatonin, testosterone and the two hormones administered in parallel on ventral prostate of the rat treated with stilbestrol in the first day of life.
    Limanowski A; Miśkowiak B; Otulakowski B
    Histol Histopathol; 1995 Oct; 10(4):869-74. PubMed ID: 8574008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A selective estrogen receptor α agonist ameliorates hepatic steatosis in the male aromatase knockout mouse.
    Chow JD; Jones ME; Prelle K; Simpson ER; Boon WC
    J Endocrinol; 2011 Sep; 210(3):323-34. PubMed ID: 21705395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic mutations resulting in estrogen insufficiency in the male.
    Simpson ER
    Mol Cell Endocrinol; 1998 Oct; 145(1-2):55-9. PubMed ID: 9922099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase-deficient (ArKO) mice have reduced blood pressure and baroreflex sensitivity.
    Head GA; Obeyesekere VR; Jones ME; Simpson ER; Krozowski ZS
    Endocrinology; 2004 Sep; 145(9):4286-91. PubMed ID: 15178650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal exposure to diethylstilbestrol permanently alters the basal and 17 beta-estradiol induced expression of c-fos proto-oncogene in mouse urethroprostatic complex.
    Salo LK; Mäkelä SI; Stancel GM; Santti RS
    Mol Cell Endocrinol; 1997 Feb; 126(2):133-41. PubMed ID: 9089651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between aromatase activity in the brain and gonads and behavioural deficits in homozygous and heterozygous aromatase knockout mice.
    Bakker J; Baillien M; Honda S; Harada N; Balthazart J
    J Neuroendocrinol; 2004 May; 16(5):483-90. PubMed ID: 15117342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Eralpha and ERbeta in the prostate: insights from genetic models and isoform-selective ligands.
    McPherson SJ; Ellem SJ; Patchev V; Fritzemeier KH; Risbridger GP
    Ernst Schering Found Symp Proc; 2006; (1):131-47. PubMed ID: 17824175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate phenotypes in estrogen-modulated transgenic mice.
    Jarred RA; McPherson SJ; Bianco JJ; Couse JF; Korach KS; Risbridger GP
    Trends Endocrinol Metab; 2002; 13(4):163-8. PubMed ID: 11943560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency.
    Takeda K; Toda K; Saibara T; Nakagawa M; Saika K; Onishi T; Sugiura T; Shizuta Y
    J Endocrinol; 2003 Feb; 176(2):237-46. PubMed ID: 12553872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.